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ABSTRACT 
Missense mutations occur close to the binding pocket of ornithine transcarbamylase 
(OTCase) enzyme associated with a severe form of ornithine transcarbamylase 
deficiency (OTCD), an X-linked disorder. These mutations affect the functions of 
OTCase enzyme in the body that can lead to acute clinical symptoms. Early diagnosis 
and intervention is crucial for effective decision on managing patients and reducing 
mortality rate. However, the current diagnosis and biochemical analyses being used 
are still time consuming, labour intensive and costly. Therefore, in this work, three (3) 
stages of computational approaches (mutation prediction servers, molecular docking, 
molecular dynamics simulations) are explored and implemented to predict the severity 
of the missense mutations in OTCD. The findings are based on two novels, Q171H 
and N199H, and 30 other known missense mutations located in the OTCase ligand 
binding pocket. The novel mutations were obtained from the nucleotide sequencing 
results from two OTCD Malaysian patients, while the other 30 known mutations were 
collected from HGMD and 1000G browser databases. The consensus prediction of 
five mutation prediction servers concluded all 32 mutations are disease-causing. 
Further study using docking of PALO ligand, an analog of N-phosphonacetyl-L-
ornithine resulted in binding of the ligand to the mutant OTCase structures with 
slightly differently conformation when compared to the wild type structure. In the 
final stage, MD simulations of the mutant complexes (Q171H-PALO, N199H-PALO, 
R92P-PALO and H168R-PALO) confirmed the conformational instability due to the 
disruption of intermolecular interactions between PALO and OTCase. The missense 
mutations disrupted hydrogen bond interactions with the neighbouring residues (S267, 
M268, D263, C303, R330 and E326), including residues involved in the catalytic 
mechanism (C303, D263 and R330). In addition, the role of SMG loop as a second 
ligand recognition site was observed during the simulations. Application of 
computational approaches successfully revealed the mutations potentially disturb 
catalytic efficiency contributing to the occurrence of various OTCD symptoms. In 
conclusion, computational approaches can potentially be used as preliminary 
screening and rapid diagnosis for new mutation as it can provide the fast result, save 
time and cost. 
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